Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia
type: MedicalStudy
description: A 3 Weeks Open Label Study to Evaluate the Efficacy in Agitation and Safety of Quetiapine Fumarate XR in Treatment of Patients With Acute Schizophrenia
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE4
start date: 2009-09
end date: 2010-04
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00954122
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: AstraZeneca
study subject: Schizophrenia
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Schizophrenia

AI Analytics
type: Organization